FRANKFURT, Germany — German drug and chemicals company Merck KgaA has reported a loss for the second quarter on one-time expenses, including the costs of integrating acquisitions Serono and Millipore.
The net loss of €86 million ($125 million) compares with a net profit of €183 million in the second quarter of 2010.
Revenues rose 16 percent to €2.55 billion.
The company cited a string of one-time charges in its earnings release Wednesday, including €161 million related to an underused factory in Switzerland and €20 million for the remaining costs of halting work on multiple sclerosis drug Cladribine.
via msnbc.msn.com
No comments:
Post a Comment